Historical record - last NADAC effective date: 2/19/2020
Product Information
AMLODIPINE-BENAZEPRIL 5-40 MG is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1677 per EA under NDC 57237014505. Its NADAC has been published 211 times since Feb 10, 2016.
FDA first approved this application on Sep 5, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 40 mg/1; mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237014505
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/19/2020
Active Ingredients
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202239FDA Approved
9/5/2012
TE Code
AB
On Market Since
9/5/2012
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-BENAZEPRIL 5-40 MG has been published 211 times since Feb 10, 2016, and over the history we have for it it has declined 58.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1677 per EA |
|---|---|
| All-time high | $0.4144 (Mar 16, 2016) |
| All-time low | $0.1267 (Jan 23, 2019) |
| Median price | $0.2199 |
| Average price | $0.2227 |
| Largest weekly change | -34.6% (Aug 22, 2018) |
| Weeks tracked | 211 |
| Tracking since | Feb 10, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-58.2%
Last surveyed Feb 19, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-BENAZEPRIL 5-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-BENAZEPRIL 5-40 MG, manufactured by Rising Pharma Holdings Inc., is $0.1677 per EA (NDC 57237014505), effective Feb 19, 2020.
How has the price of AMLODIPINE-BENAZEPRIL 5-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-BENAZEPRIL 5-40 MG has declined 58.2%. It has been tracked across 211 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-BENAZEPRIL 5-40 MG?
Since Feb 10, 2016, the NADAC for AMLODIPINE-BENAZEPRIL 5-40 MG has ranged from a low of $0.1267 (Jan 23, 2019) to a high of $0.4144 (Mar 16, 2016), with a median of $0.2199 per EA.
Are there cheaper alternatives to AMLODIPINE-BENAZEPRIL 5-40 MG?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-BENAZEPRIL 5-40 MG, is $0.1472 per EA — about 12% below AMLODIPINE-BENAZEPRIL 5-40 MG.
Who manufactures AMLODIPINE-BENAZEPRIL 5-40 MG?
AMLODIPINE-BENAZEPRIL 5-40 MG (NDC 57237014505) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.